Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALISKIREN HEMIFUMARATE Cause Off label use? 10 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Off label use have been filed in association with ALISKIREN HEMIFUMARATE (Aliskiren). This represents 2.0% of all adverse event reports for ALISKIREN HEMIFUMARATE.

10
Reports of Off label use with ALISKIREN HEMIFUMARATE
2.0%
of all ALISKIREN HEMIFUMARATE reports
3
Deaths
3
Hospitalizations

How Dangerous Is Off label use From ALISKIREN HEMIFUMARATE?

Of the 10 reports, 3 (30.0%) resulted in death, 3 (30.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALISKIREN HEMIFUMARATE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does ALISKIREN HEMIFUMARATE Cause?

Nausea (227) Fall (214) Cerebrovascular accident (196) Anxiety (195) Fatigue (186) Confusional state (185) Muscular weakness (184) Hemiparesis (181) Hemiplegia (181) Muscle spasticity (181)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which ALISKIREN HEMIFUMARATE Alternatives Have Lower Off label use Risk?

ALISKIREN HEMIFUMARATE vs ALISKIREN\HYDROCHLOROTHIAZIDE ALISKIREN HEMIFUMARATE vs ALIZAPRIDE ALISKIREN HEMIFUMARATE vs ALLANTOIN ALISKIREN HEMIFUMARATE vs ALLEGRA ALISKIREN HEMIFUMARATE vs ALLEGRA 24 HOUR

Related Pages

ALISKIREN HEMIFUMARATE Full Profile All Off label use Reports All Drugs Causing Off label use ALISKIREN HEMIFUMARATE Demographics